Figure 10.
Engraftment profiles and clinical outcome in two renal cell carcinoma (RCC) patients with a delayed graft-versus-tumor (GVT) effect after nonmyeloablative transplantation.
Patient A had a delayed GVT effect in the absence of acute or chronic graft-versus-host disease (GVHD), while patient B had disease regression following a donor lymphocyte infusion (DLI) in association with acute GVHD.
Abbreviations: CSA, cyclosporine.